231 related articles for article (PubMed ID: 20888494)
21. Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease.
Brickley-Parsons D; Glimcher MJ; Smith RJ; Albin R; Adams JP
J Bone Joint Surg Am; 1981 Jun; 63(5):787-97. PubMed ID: 7240301
[TBL] [Abstract][Full Text] [Related]
22. Prostaglandins influence myofibroblast contractility in Dupuytren's disease.
Badalamente MA; Hurst LC; Sampson SP
J Hand Surg Am; 1988 Nov; 13(6):867-71. PubMed ID: 3225412
[TBL] [Abstract][Full Text] [Related]
23. Cellular structure and biology of Dupuytren's disease.
Tomasek JJ; Vaughan MB; Haaksma CJ
Hand Clin; 1999 Feb; 15(1):21-34. PubMed ID: 10050239
[TBL] [Abstract][Full Text] [Related]
24. Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren's disease and adjacent palmar fascia cells.
Vi L; Feng L; Zhu RD; Wu Y; Satish L; Gan BS; O'Gorman DB
Exp Cell Res; 2009 Dec; 315(20):3574-86. PubMed ID: 19619531
[TBL] [Abstract][Full Text] [Related]
25. The effect of 5-fluorouracil on Dupuytren fibroblast proliferation and differentiation.
Jemec B; Linge C; Grobbelaar AO; Smith PJ; Sanders R; McGrouther DA
Chir Main; 2000 Feb; 19(1):15-22. PubMed ID: 10777424
[TBL] [Abstract][Full Text] [Related]
26. Temporal spatial expression and function of non-muscle myosin II isoforms IIA and IIB in scar remodeling.
Bond JE; Ho TQ; Selim MA; Hunter CL; Bowers EV; Levinson H
Lab Invest; 2011 Apr; 91(4):499-508. PubMed ID: 21102503
[TBL] [Abstract][Full Text] [Related]
27. Distinctive G protein-dependent signaling in smooth muscle by sphingosine 1-phosphate receptors S1P1 and S1P2.
Zhou H; Murthy KS
Am J Physiol Cell Physiol; 2004 May; 286(5):C1130-8. PubMed ID: 15075212
[TBL] [Abstract][Full Text] [Related]
28. The cytoskeleton and extracellular matrix of the Dupuytren's disease "myofibroblast": an immunofluorescence study of a nonmuscle cell type.
Tomasek JJ; Schultz RJ; Episalla CW; Newman SA
J Hand Surg Am; 1986 May; 11(3):365-71. PubMed ID: 3519746
[TBL] [Abstract][Full Text] [Related]
29. Transforming growth factor-beta1 stimulation enhances Dupuytren's fibroblast contraction in response to uniaxial mechanical load within a 3-dimensional collagen gel.
Bisson MA; Beckett KS; McGrouther DA; Grobbelaar AO; Mudera V
J Hand Surg Am; 2009; 34(6):1102-10. PubMed ID: 19505772
[TBL] [Abstract][Full Text] [Related]
30. Myofibroblast distribution in Dupuytren's cords: correlation with digital contracture.
Verjee LS; Midwood K; Davidson D; Essex D; Sandison A; Nanchahal J
J Hand Surg Am; 2009 Dec; 34(10):1785-94. PubMed ID: 19910144
[TBL] [Abstract][Full Text] [Related]
31. Feedback inhibition of high TGF-beta1 concentrations on myofibroblast induction and contraction by Dupuytren's fibroblasts.
Wong M; Mudera V
J Hand Surg Br; 2006 Oct; 31(5):473-83. PubMed ID: 16875762
[TBL] [Abstract][Full Text] [Related]
32. Sphingosine-1-phosphate and sphingosine kinase are critical for transforming growth factor-beta-stimulated collagen production by cardiac fibroblasts.
Gellings Lowe N; Swaney JS; Moreno KM; Sabbadini RA
Cardiovasc Res; 2009 May; 82(2):303-12. PubMed ID: 19228708
[TBL] [Abstract][Full Text] [Related]
33. Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease.
Ulrich D; Ulrich F; Piatkowski A; Pallua N
Arch Orthop Trauma Surg; 2009 Nov; 129(11):1453-9. PubMed ID: 18758795
[TBL] [Abstract][Full Text] [Related]
34. Androgen receptors in Dupuytren's contracture.
Pagnotta A; Specchia N; Greco F
J Orthop Res; 2002 Jan; 20(1):163-8. PubMed ID: 11853085
[TBL] [Abstract][Full Text] [Related]
35. The myofibroblast in Dupuytren's contracture.
Rudolph R; Vande Berg J
Hand Clin; 1991 Nov; 7(4):683-92; discussion 693-4. PubMed ID: 1769990
[TBL] [Abstract][Full Text] [Related]
36. The role of the fibroblast in Dupuytren's contracture.
Murrell GA
Hand Clin; 1991 Nov; 7(4):669-80; discussion 681. PubMed ID: 1769989
[TBL] [Abstract][Full Text] [Related]
37. Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation by activating separate serum response factor co-factors.
Lockman K; Hinson JS; Medlin MD; Morris D; Taylor JM; Mack CP
J Biol Chem; 2004 Oct; 279(41):42422-30. PubMed ID: 15292266
[TBL] [Abstract][Full Text] [Related]
38. [Pathogenesis of Dupuytren's contracture--a review].
Koźma EM; Olczyk K; Bobiński R; Kasperczyk M; Szpyra K
Chir Narzadow Ruchu Ortop Pol; 2002; 67(1):73-9. PubMed ID: 12087679
[TBL] [Abstract][Full Text] [Related]
39. Responsiveness of Dupuytren's disease fibroblasts to 5 alpha-dihydrotestosterone.
Pagnotta A; Specchia N; Soccetti A; Manzotti S; Greco F
J Hand Surg Am; 2003 Nov; 28(6):1029-34. PubMed ID: 14642522
[TBL] [Abstract][Full Text] [Related]
40. Sphingosine-1-phosphate induced contraction of bladder smooth muscle.
Kendig DM; Matsumoto AK; Moreland RS
Eur J Pharmacol; 2013 Nov; 720(1-3):355-62. PubMed ID: 24120660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
